Your browser doesn't support javascript.
loading
Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer.
Wang, Yixing; Fu, Sha; Zhang, Xuanye; Du, Wei; Luo, Linfeng; Jiang, Yongluo; Zhou, Yixin; Zhao, Yuanyuan; Yang, Yunpeng; Zhao, Hongyun; Fang, Wenfeng; Huang, Yan; Zhang, Li; Hong, Shaodong.
Afiliação
  • Wang Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Fu S; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang X; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Du W; Department of Cellular & Molecular Diagnostics Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Luo L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation of Sun Yat-Sen University, Guangzhou, China.
  • Jiang Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Zhou Y; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhao Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Zhao H; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Fang W; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Zhang L; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Hong S; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Front Immunol ; 14: 1151385, 2023.
Article em En | MEDLINE | ID: mdl-37313402

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article